Literature DB >> 18463132

Adjusting for bias and unmeasured confounding in Mendelian randomization studies with binary responses.

Tom M Palmer1, John R Thompson, Martin D Tobin, Nuala A Sheehan, Paul R Burton.   

Abstract

BACKGROUND: Mendelian randomization uses a carefully selected gene as an instrumental-variable (IV) to test or estimate an association between a phenotype and a disease. Classical IV analysis assumes linear relationships between the variables, but disease status is often binary and modelled by a logistic regression. When the linearity assumption between the variables does not hold the IV estimates will be biased. The extent of this bias in the phenotype-disease log odds ratio of a Mendelian randomization study is investigated.
METHODS: Three estimators termed direct, standard IV and adjusted IV, of the phenotype-disease log odds ratio are compared through a simulation study which incorporates unmeasured confounding. The simulations are verified using formulae relating marginal and conditional estimates given in the Appendix.
RESULTS: The simulations show that the direct estimator is biased by unmeasured confounding factors and the standard IV estimator is attenuated towards the null. Under most circumstances the adjusted IV estimator has the smallest bias, although it has inflated type I error when the unmeasured confounders have a large effect.
CONCLUSIONS: In a Mendelian randomization study with a binary disease outcome the bias associated with estimating the phenotype-disease log odds ratio may be of practical importance and so estimates should be subject to a sensitivity analysis against different amounts of hypothesized confounding.

Mesh:

Year:  2008        PMID: 18463132     DOI: 10.1093/ije/dyn080

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  30 in total

1.  A Bayesian approach for instrumental variable analysis with censored time-to-event outcome.

Authors:  Gang Li; Xuyang Lu
Journal:  Stat Med       Date:  2014-11-13       Impact factor: 2.373

2.  Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants.

Authors:  Brandon L Pierce; Habibul Ahsan; Tyler J Vanderweele
Journal:  Int J Epidemiol       Date:  2010-09-02       Impact factor: 7.196

Review 3.  Methodological challenges in mendelian randomization.

Authors:  Tyler J VanderWeele; Eric J Tchetgen Tchetgen; Marilyn Cornelis; Peter Kraft
Journal:  Epidemiology       Date:  2014-05       Impact factor: 4.822

4.  Bayesian methods for instrumental variable analysis with genetic instruments ('Mendelian randomization'): example with urate transporter SLC2A9 as an instrumental variable for effect of urate levels on metabolic syndrome.

Authors:  Paul M McKeigue; Harry Campbell; Sarah Wild; Veronique Vitart; Caroline Hayward; Igor Rudan; Alan F Wright; James F Wilson
Journal:  Int J Epidemiol       Date:  2010-03-25       Impact factor: 7.196

5.  Mendelian randomization studies for a continuous exposure under case-control sampling.

Authors:  James Y Dai; Xinyi Cindy Zhang
Journal:  Am J Epidemiol       Date:  2015-02-21       Impact factor: 4.897

6.  Commentary: building an evidence base for mendelian randomization studies: assessing the validity and strength of proposed genetic instrumental variables.

Authors:  Eric J Tchetgen Tchetgen; Stefan Walter; M Maria Glymour
Journal:  Int J Epidemiol       Date:  2013-02       Impact factor: 7.196

7.  Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study.

Authors:  Aaron P Thrift; Nicholas J Shaheen; Marilie D Gammon; Leslie Bernstein; Brian J Reid; Lynn Onstad; Harvey A Risch; Geoffrey Liu; Nigel C Bird; Anna H Wu; Douglas A Corley; Yvonne Romero; Stephen J Chanock; Wong-Ho Chow; Alan G Casson; David M Levine; Rui Zhang; Weronica E Ek; Stuart MacGregor; Weimin Ye; Laura J Hardie; Thomas L Vaughan; David C Whiteman
Journal:  J Natl Cancer Inst       Date:  2014-09-30       Impact factor: 13.506

Review 8.  Mendelian Randomization as an Approach to Assess Causality Using Observational Data.

Authors:  Peggy Sekula; Fabiola Del Greco M; Cristian Pattaro; Anna Köttgen
Journal:  J Am Soc Nephrol       Date:  2016-08-02       Impact factor: 10.121

9.  The causal roles of vitamin B(12) and transcobalamin in prostate cancer: can Mendelian randomization analysis provide definitive answers?

Authors:  Simon M Collin; Chris Metcalfe; Tom M Palmer; Helga Refsum; Sarah J Lewis; George Davey Smith; Angela Cox; Michael Davis; Gemma Marsden; Carole Johnston; J Athene Lane; Jenny L Donovan; David E Neal; Freddie C Hamdy; A David Smith; Richard M Martin
Journal:  Int J Mol Epidemiol Genet       Date:  2011-11-28

Review 10.  Usefulness of Mendelian randomization in observational epidemiology.

Authors:  Murielle Bochud; Valentin Rousson
Journal:  Int J Environ Res Public Health       Date:  2010-02-26       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.